Malaysia Pharmaceuticals & Healthcare Q2 2019
Government investment will support future growth of the Malaysian pharmaceutical and healthcare industry. Malaysia's2019 budget proposes an increase in public healthcare expenditure, and the government will continue to push forward withfundamental healthcare initiatives. However, we note that innovative drugmakers will continue to struggle due to the country'schallenging regulatory environment in addition to growing generic substitution rhetoric as the rationalisation of the pharmaceuticalbudget becomes more important.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook